Stock SINCLAIR PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Sinclair Pharma PLC

Equities

GB0033856740

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sinclair Pharma : Interim Results 2018
PU
European shares bounce as trade deal hopes lift risk appetite
RE
Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)
RE
Huadong Medicine : Sinclair Pharma says Chinese firms given more time to make takeover offer
RE
Huadong Medicine : Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares soar
RE
Sinclair Pharma : announces $5 million investment by EW Healthcare Partners via convertible loan
PU
Sinclair Pharma : and ThermiGen terminate US distribution agreement
PU
Sinclair Pharma : Aesthetic surgery journal confirms efficacy and consumer acceptance of absorbable suture suspension
PU
Sinclair Pharma : Director/PDMR Shareholding
PU
Sinclair Pharma : Ellansé® Approved for Sale in Brazil
PU
Sinclair Pharma : Ellansé Approved for Brazil
PU
Sinclair Pharma : Trading Statement
PU
Sinclair Pharma : first-half sales up 16 percent, sees momentum continuing
RE
Alliance Pharma : first-half revenue rises on strong sales abroad
RE
Sinclair Pharma : Trading Update for the 6 months to 30 June 2017
PU
Sinclair Pharma : Holding(s) in Company
PU
Sinclair Pharma : Acquisition of Worldwide rights to the Refine™ Support System, an FDA cleared suture based breast-lifting technology
PU
Sinclair Pharma : Notice of AGM
PU
Sinclair Pharma : Preliminary Results
PU
Sinclair Pharma : Settlement Agreement with Sinclair Pharma plc
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Sinclair Pharma PLC